Professional Documents
Culture Documents
Aylin Angulo Infectious Diseases and Vaccinations 1
Aylin Angulo Infectious Diseases and Vaccinations 1
HPS 405
In 1947, the Zika Virus (ZIKV) was first accidentally isolated from a monkey with yellow
fever in Uganda (Gubler et al, 2017). Afterwards, mice were inoculated with ZIKV and after ten
days of exposure mice remained asymptomatic(Gubler et al, 2017). Unlike other vector borne
disease, mice that were inoculated with ZIKV had no signs or symptoms of disease (Gubler et al,
2017). In 1962, the first confirmed human Zika virus infection occurred (Gubler et al, 2017).
During this time, it was very difficult to differentiate due to similarity of other vector-borne
diseases such as yellow fever, dengue, and many others (Gubler et al, 2017). In 1966, ZIKV was
then isolated from mosquitos in Malaysia specifically in Aedes aegypti (Gubler et al, 2017).
Serosurveys were conducted from 1950 to 1970 and suggested that Zika virus was transmitted
The first confirmed outbreak of ZIKV occurred in Yap State, Western Pacific from 2013 to
2014, where it presented Dengue-like symptoms, but some patients were asymptomatic which
raised questions to the associated virus (Gubler et al, 2017). The next outbreak of Zika virus was
during 2013 in French Polynesia, which is when the association between Guillain-Barre
Syndrome (GBS) and ZIKV was discovered (Gubler et al, 2017). GBS can lead to paralysis due
to the immune system attacking certain parts of the peripheral nervous system (Hughes, 2012).
ZIKV began gaining attention in 2015, when it emerged in Brazil and confirmations of it causing
microcephaly were validated (Gubler et al, 2017). In the past ten years, ZIKV has affected over
80 countries and approximately thirty-one countries have reported higher rates of microcephaly
and other central nervous system (CNS) issues associated with the Zika virus (Gubler et al,
2017).
One of the most distinguishing characteristics of the Zika virus is its ability to rapidly mutate
its genome. This is caused by its ribonucleic acid(RNA)- dependent RNA polymerase (Gubler et
al, 2017). It is estimated that after each genome replication there is approximately one mutation
(Gubler et al, 2017). This quick adaptive feature contributes to the transmission of Zika through
majority of the planet (Gubler et al, 2017). Its ability to quickly adapt could have contributed to
it spread in different climates which include temperatures and pressure changes (Gubler et al,
2017).
The amount of genetic and behavioral risk factors for Zika are very minimal, but there are
various environmental risk factors identified. Inhabitants of tropical areas are at higher risk since
ZIKV is a vector borne disease primarily transmitted using the help of Aedes aegypti (Paixão et
al, 2016). A link between heavy rainfall and ZIKV outbreaks has been associated due to the
presence of stagnant water (Fuller et al, 2017). Currently, the focus of prevention has been on
pregnant women or future mothers due to the ZIKV being able to cross the placenta and affecting
The effects of the zika virus and initiatives can be interpreted through the socioecological
model. On the intrapersonal level, we can see how a child’s life is affected by the presence of
interactions with peers. This can later lead to stress due to the problems listed above. Using the
intrapersonal level, the child can receive additional resources especially during the course of
their studies. On the interpersonal level, the effect of having a child with microcephaly can be
seen within the parents whether it is the added stress of having to take their child to multiple
doctor’s appointments or the financial burden of medical bills. Certain initiatives may help
educate parents and family members on what microcephaly is and how it affects their child. On a
community level, disseminating information about the side effects of ZIKV such as
programs for children with neurological disabilities that still have an inclusive component would
help individuals who may be suffering from the side effects of ZIKV. On a policy level, creating
new research initiatives on how to reduce susceptibility to vector-borne diseases such as Zika.
The prevention of Zika transmission can also be incorporated into the socioecological model.
On the intrapersonal level, individuals can be informed about wearing insect repellents and
staying actively up to date of risk areas. On an interpersonal level, women planning to become
pregnant should be tested to see if they have been exposed to ZIKV. This may reduce the level of
level, stagnant water that may attract mosquitos should be removed as soon as possible. On an
organizational level, field trap barrier systems that reduce the number of mosquitos should be
implemented into schools, workplaces, and other places where large numbers of community
members meet. On a policy level, legislation should be created that will help minimize costs of
repellent, bed nets, and other equipment that deters mosquito bites.
A successful intervention that not only decreases Zika, but also other vector borne diseases
such as dengue and chikungunya diseases is the use of field trap barrier system (Akhoundi et al,
2018). The study targeted Aedes aegypti and Aedes albopictus mosquitos, but it also eliminated
other mosquitos present (Akhoundi et al, 2018). A field trap barrier system uses target specific
attractants which later kills them. The study was conducted from July 2016 to September 2016
and included 800 houses in France (Akhoundi et al, 2018). The trap barrier system being utilized
was BioBelt Anti-Moustiques (Akhoundi et al, 2018). The intervention was successful at
reducing the biting rate of mosquitos in houses with trap barrier systems (Akhoundi et al, 2018).
It also reduced the biting rates in nearby houses due to the spillover effect (Akhoundi et al,
2018). This intervention was based on the community level of the socioecological due to creating
intervention primarily focused on the organizational level of the socioecological model since it
was based out of local schools. At the beginning of the intervention, the insecticide treated
uniforms where highly effective, but after a couple washes the insecticide began to dilute
(Kittayapong et al, 2017). The insecticide used is called Permethrin which was not expected to
wash out when the study design was created (Kittayapong et al, 2017). After twenty washes, the
effectiveness of the insecticide was well below 20%. After seventy washes, the permethrin had
zero effect on neighboring mosquitos (Kittayapong et al, 2017). Another complication of the
study is that researchers do not know the long-term effect Permethrin may have on individuals
(Kittayapong et al, 2017). This study cannot be directly translated to intervening the effects of
zika since the effects of ZIKV are mostly affecting pregnant women.
Both of these interventions were not specifically geared towards prevention of ZIKV, but
they did target the main vectors which are Aedes aegypti and Aedes albopictus (Gubler et al,
2017). At the end of both interventions, they did include a brief discussion of the effect it may
have on ZIKV. Since the effects of Zika are fairly new, there are very few interventions which is
from this actively mutating virus? Zika virus has been silently transmitting through certain
geographical regions, but now it is affecting hosts by creating neurological complications such as
GBS and microcephaly. ZIKV is a public health issue due to globalization, an actively mutating
Akhoundi, M., Jourdain, F., Chandre, F., Delaunay, P., & Roiz, D. (2018). Effectiveness of a
field trap barrier system for controlling Aedes albopictus: a “removal trapping” strategy.
Gubler, D. J., Vasilakis, N., & Musso, D. (2017). History and emergence of Zika virus. The
Fuller, T., Calvet, G. A., Estevam, C. G., Brasil, P., Angelo, J. R., Smith, T. B., & Di Filippis, A.
M. B. (2017). Environmental and Climatic Risk Factors for Zika and Chikungunya Virus
Infections in Rio de Janeiro, Brazil, 2015–2016. (Vol. 4, No. Suppl 1, p. S56). Oxford
University Press.
Kittayapong, P., Olanratmanee, P., Maskhao, P., Byass, P., Logan, J., Tozan, Y., ... & Wilder-
diseases, 11(1).
Paixão, E. S., Barreto, F., da Glória Teixeira, M., da Conceição N. Costa, M., & Rodrigues, L. C.